BEAT Stock Summary and Trading Ideas (Heartbeam | NASDAQ:BEAT)

HeartBeam Inc is a medical technology company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.

What symbol and exchange does Heartbeam shares trade?

Heartbeam trades on the NASDAQ stock market under the symbol BEAT.

What is Heartbeam stock price doing today?

As of December 31, 2025, BEAT stock price climbed to $2.40 with 1,056,688 million shares trading.

What is Heartbeam's Beta?

BEAT has a beta of 0.84, meaning it tends to be less sensitive to market movements. BEAT has a correlation of 0.01 to the broad based SPY ETF.

How much is Heartbeam worth?

BEAT has a market cap of $82.66 million. This is considered a Micro Cap stock.

How much money does Heartbeam make?

Last quarter Heartbeam reported $0 in Revenue and -$.15 earnings per share. This fell short of revenue expectation by $-1 million and exceeded earnings estimates by $.01.

What is the highest and lowest price Heartbeam traded in the last 3 year period?

In the last 3 years, BEAT traded as high as $5.06 and as low as $.54.

What are the top ETFs holding Heartbeam?

The top ETF exchange traded funds that BEAT belongs to (by Net Assets): VTI, VXF, IWC.

Is Heartbeam (BEAT) a good investment?

BEAT has underperformed the market in the last year with a price return of +11.1% while the SPY ETF gained +17.2%. However, in the short term, BEAT had mixed performance relative to the market. It has outperformed in the last 3 months, returning +45.5% vs +2.7% return in SPY. But in the last 2 weeks, BEAT shares have been beat by the market, returning -30.2% compared to an SPY return of +0.7%.

What are the support and resistance levels for Heartbeam (BEAT)?

BEAT support price is $2.04 and resistance is $2.51 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BEAT shares will trade within this expected range on the day.